State Street’s Champions Oncology CSBR Stock Holding History

State Street’s Portfolio CSBR Stock Details CSBR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$151K	Hold	26,203	–	–	﹤0.01%	3956
2025 Q4	$181K	Hold	26,203	–	–	﹤0.01%	3917
2025 Q3	$170K	Hold	26,203	–	–	﹤0.01%	3953
2025 Q2	$193K	Hold	26,203	–	–	﹤0.01%	3847
2025 Q1	$227K	Sell	26,203 -350	-1%	-$3.55K	﹤0.01%	3793
2024 Q4	$228K	Hold	26,553	–	–	﹤0.01%	3821
2024 Q3	$129K	Hold	26,553	–	–	﹤0.01%	3928
2024 Q2	$137K	Hold	26,553	–	–	﹤0.01%	3922
2024 Q1	$130K	Hold	26,553	–	–	﹤0.01%	3978
2023 Q4	$144K	Hold	26,553	–	–	﹤0.01%	3967
2023 Q3	$165K	Hold	26,553	–	–	﹤0.01%	3988
2023 Q2	$167K	Hold	26,553	–	–	﹤0.01%	4052
2023 Q1	$107K	Hold	26,553	–	–	﹤0.01%	4305
2022 Q4	$120K	Hold	26,553	–	–	﹤0.01%	4314
2022 Q3	$199K	Hold	26,553	–	–	﹤0.01%	4144
2022 Q2	$215K	Hold	26,553	–	–	﹤0.01%	4159
2022 Q1	$216K	Buy	26,553 +1,990	+8%	+$16K	﹤0.01%	4353
2021 Q4	$197K	Hold	24,563	–	–	﹤0.01%	4356
2021 Q3	$251K	Buy	24,563 +400	+2%	+$4.07K	﹤0.01%	4273
2021 Q2	$248K	Sell	24,163 -77,300	-76%	-$784K	﹤0.01%	4130
2021 Q1	$1.15M	Buy	101,463 +5,800	+6%	+$67.3K	﹤0.01%	3590
2020 Q4	$1.03M	Buy	95,663 +26,226	+38%	+$270K	﹤0.01%	3552
2020 Q3	$642K	Sell	69,437 -2,633	-4%	-$23.4K	﹤0.01%	3534
2020 Q2	$689K	Buy	+72,070	New	+$614K	﹤0.01%	3491

Other funds holding CSBR

BMC

Battery Management Corp Boston, Massachusetts $426M AUM 21.5% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

TAM

Tocqueville Asset Management New York $6.74B AUM 32.29% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

MBAM

Mink Brook Asset Management West Palm Beach, Florida $179M AUM 37.68% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

State Street's CSBR Position: Q1 2026 in Review

State Street held its Champions Oncology (CSBR) position steady in Q1 2026 at 26,203 shares worth $151K. The position accounts for ﹤0.01% of the portfolio, ranked #3956.

State Street first reported a position in CSBR in Q2 2020 and has held it in 24 quarters since. The position peaked at $1.15M in Q1 2021. 25 funds tracked by Wall St. Rank hold CSBR as of Q1 2026.

State Street held 26,203 shares of Champions Oncology worth $151K as of Q1 2026.
State Street left its Champions Oncology share count unchanged in Q1 2026.
Champions Oncology made up ﹤0.01% of State Street's portfolio in Q1 2026, its #3956 holding.
State Street first reported a position in Champions Oncology in Q2 2020 and has held it in 24 quarters since.
State Street's Champions Oncology position peaked at $1.15M in Q1 2021.
25 funds tracked by Wall St. Rank held Champions Oncology as of Q1 2026.

Based on State Street's 13F filing for Q1 2026, filed 15 May 2026.